Aggressive natural killer-cell neoplasm presenting in the marrow: a report of two cases including one with gains of chromosomes 4q and 9p by Jie-Yang Jhuang et al.
CASE REPORT Open Access
Aggressive natural killer-cell neoplasm
presenting in the marrow: a report of two cases
including one with gains of chromosomes
4q and 9p
Jie-Yang Jhuang1, Alexandra Clipson2, Yen-Chuan Hsieh3, Chun-Chieh Yang4, Sheng-Tsung Chang3,5,
Ming-Qing Du2 and Shih-Sung Chuang3,6*
Abstract
Aggressive nature killer (NK)-cell neoplasm includes aggressive NK-cell leukemia (ANKL) and extranodal
NK/T-cell lymphoma (ENKTL), nasal type. ANKL is rare and is characterized by a systemic neoplastic
proliferation of NK-cells, usually with a leukemic presentation. ENKTL is a predominantly extranodal
lymphoma, occurring mainly in the upper aerodigestive tract. Both are aggressive neoplasms strongly
associated with Epstein-Barr virus (EBV). Here we report two patients with aggressive NK-cells neoplasms
localized in the bone marrow (BM) who presented as prolonged fever, anemia, and thrombocytopenia. Both
were treated initially as infectious disease. Imaging studies revealed splenomegaly without any nodular lesion
or lymphadenopathy. BM examination revealed extensive involvement by EBV-positive NK-cells in both cases.
Staging workup including nasal examination/biopsy was negative. Both patients passed away in a month. One
case showed gains of chromosomes 4q and 9p by array comparative genomic hybridization. Both tumors were
diagnostically challenging due to the unusual clinical presentation and absence of leukemic change, tumor mass or
lymphadenopathy. Our cases demonstrate that lymphoma should be considered in patients with fever of unknown
origin and bone marrow aspiration/biopsy should be performed as early diagnosis and novel therapeutic regimens
may benefit these patients.
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Background
In the 2008 WHO classification, aggressive nature killer
(NK)-cell neoplasms include 2 entities: aggressive NK-
cell leukemia (ANKL) and extranodal NK/T-cell lymph-
oma, nasal type (ENKTL) [1, 2]. ANKL is rare and
characterized by a systemic neoplastic proliferation of
NK-cells almost always associated with Epstein-Barr
virus (EBV), usually with a leukemic presentation, and
an aggressive clinical course. ANKL affects mostly young
to middle-aged patients and is more common among
Asians. ENKTL is a predominantly extranodal lymphoma
occurring mainly in upper aerodigestive tract. It is associ-
ated with EBV and has a strong ethnic and geographic
predilection, being most common among Asians and
Native Americans. The distinction between prototypic
ANKL and ENKTL is usually straight forward, yet rare
cases with overlapping features may exist. Molecular fea-
tures have been reported to be different between these en-
tities [3]. Here, we report two cases of aggressive NK-cell
neoplasms involving BM but without leukemic phase or
extranodal involvement. Furthermore, one case showed
gains of chromosomes 4q and 9p by array comparative
genomic hybridization (aCGH).
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Case presentation
Case 1 was a 55-year-old Taiwanese female presenting on
Oct 18th, 2009 with abdominal pain and fluctuating fever
for several weeks. There was no prior systemic disease, B
symptoms, lymphadenopathy, or skin rashes. Hemograms
showed normocytic anemia (hemoglobin at 8.6 g/dL),
thrombocytopenia (platelet count at 37,000/μL), and nor-
mal white counts without blasts or leukemic cells. Whole
body gallium scan revealed increased uptake only at the
bilateral lower lung fields but not in the nasopharynx or
elsewhere including spleen. Computed tomography (CT)
scans of the chest revealed mixed consolidation and
ground-glass opacity over bilateral lower lung zones
without mass lesions. Empirical antibiotics were adminis-
tered but in vain. Bone marrow (BM) biopsy was performed
on the 9th admission day and ENKTL with extensive
marrow involvement was diagnosed. Her serum lactate
dehydrogenase (LDH) level was elevated at 395 IU/L
(reference: 85–227). Abdominal CT scans were negative
for lymphadenopathy or mass lesion in the liver or
spleen. Nasal endoscopy and biopsy were negative. Her
serum EBV viral load was 130,000 copies/ml. A stage
IVB disease with ECOG performance status score of 1
and IPI score of 2 was diagnosed. She received one
course of chemotherapy with vincristine and prednisol-
one but developed metabolic acidosis. Unfortunately,
her clinical condition deteriorated rapidly and she died
of septic shock with multiple organ failure, five weeks
after admission and three weeks after diagnosis.
Table 1 summaries the pathological and immunophe-
notypic features. By flow cytometry, the marrow lym-
phocytes expressed CD2, CD56 and cytoplasmic CD3
but not surface CD3, CD5, CD7, CD8 or terminal deoxy-
nucleotidyl transferase, indicating an NK-cell phenotype
(Fig. 1a-c). The marrow trephine was hypercellular with
a diffuse infiltrate of atypical small to medium-sized
lymphocytes accompanied by stromal fibrosis (Fig. 1d
and e). Immunohistochemically, the atypical lympho-
cytes expressed CD3 (Fig. 1f ), CD45 and T-cell intracel-
lular antigen (TIA)-1 (Fig. 1g) but not CD2, CD4, CD5,
CD7, CD8, CD20, CD30, CD56, βF1, T-cell receptor
(TCR)-γ or granzyme B. EBV in situ hybridization
(EBER) showed positive signals in around 70 % tumor
cells (Fig. 1h). For Infinium genotyping assay, 200 ng
DNA isolated from marrow aspirate was hybridized to
the HumanCytoSNP-12 Beadchip (Illumina) according
to the manufacturer’s instructions. Data were analyzed
using the genotyping module of the GenomeStudio soft-
ware (version 1.9.0; Illumina). Copy-number analysis was
performed using the cnvPartition copy-number variation
(CNV) analysis plug-in for GenomeStudio software (ver-
sion 3.2.0; Illumina). A confidence value of greater than
100 was used to determine true copy number changes.
The copy number analysis indicated a gain of 1 copy at
chromosome 4:83644676 – 4:190742692 (CNV Confi-
dence: 22884.3; Fig. 1i) and a gain of 1 copy in chromo-
some 9:46587 – 9:21925855 (CNV Confidence: 1630.9)
and 9:22098574 – 9:33228189 (CNV Confidence: 2317.0;
Fig. 1j) B allele frequency (BAF) plot in both panels
demonstrated an altered pattern of BAF (0.0, 0.33, 0.67
and 1.0), while Log R ratio plot displayed no apparent
alteration. This was most likely due to the presence of
mosaicism in the region of chromosomal gain [4].
Case 2, a 63-year-old Taiwanese male, presented with
abdominal fullness for five days on Sep 25th, 2013.
Physical examination revealed a flat abdomen devoid
of tenderness, rebounding pain or lymphadenopathy.
Hemograms showed anemia (hemoglobin at 7.4 g/dL),
thrombocytopenia (platelet count at 85,000/μL), and
normal white count with presence of myelocytes and nu-
cleated red blood cells (NRBC). There were no blasts or
leukemic cells. Laboratory examination revealed elevated
LDH level (512 IU/L), abnormal liver and renal function
tests, hyperlactatemia, and abnormal inflammatory pa-
rameters. CT scans revealed a grade 1 laceration of the
slightly enlarged spleen with hemoperitoneum and con-
trast extravasation without any hepatic lesion or lymph-
adenopathy. Trans-arterial embolization restored the
hemodynamic status with stable hemoglobin level. Dur-
ing hospitalization, lactic acidosis worsened. BM biopsy
Table 1 Pathological, immunophenotypical and genotypical
findings
Case 1 Case 2
Cell size Small to medium Small to medium
Tumor necrosis Absent Present
CD2 - -
CD3 + +








CD56 (FCM)* + ND
TIA-1 + +




aFCM, flow cytometric immunophenotyping using bone marrow aspirate
Abbreviations: ND, not done; sCD3, surface CD3; TCR-GR, T-cell receptor
gene rearrangement
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Fig. 1 (See legend on next page.)
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was performed on the 30th admission day and a diagno-
sis of ENKTL was made. Serology tests showed elevated
EBV-CA IgG, EBV-CA IgA, and EBNA IgG. The serum
EBV viral load was 60,000copies/ml. Examination of the
upper airway by an otorhinolaryngologist with a nasal
biopsy was negative. His ECOG performance status
score deteriorated to 4, and he subsequently developed
acute oliguric renal failure and hepatic failure. He received
only supportive treatment and passed away on the 34th
day, one week after pathological diagnosis.
Marrow biopsy of Case 2 showed extensive coagulative
necrosis with a remaining small proportion of viable cells
at the periphery of the marrow core (Fig. 2a and b). Mor-
phologically, it was difficult to identify the atypical lymph-
oid cells (Fig. 2c). Immunohistochemical stain with CD3
(Fig. 2d) highlighted the small to medium-sized, poly-
morphous lymphocytes, including those in the necrotic
areas. These cells also expressed CD7, CD8, and TIA-1
(Fig. 2e) and were positive for EBER (Fig. 2f and g) but not
CD2, CD4, CD5, CD56, βF1 or TCR-γ. Clonality study for
TCR-γ chain gene was polyclonal for both cases using our
previously described protocols [5]. There was no fresh/
frozen tissue for copy number analysis.
Discussion
Primary BM lymphoma (PBML) is rare with poorly
defined clinicopathological features. Martinez et al.
proposed the following criteria for PBML: isolated BM
infiltration with no evidence of nodal or extranodal
disease and the exclusion of leukemias/lymphomas
that are considered to be primarily involving BM [6].
Both of our patients presented as fever of unknown
origin (FUO), anemia, and thrombocytopenia and were
treated as infectious disease until BM examination. One
main question is, if the bone marrow involvement in our
cases represent (i) ANKL, (ii) disseminated ENTKL with
Fig. 2 Case 2. Scanning (a) and medium-powers (b) of the marrow core show extensive coagulative necrosis with scanty viable cells in the right-side
end of the core. Even in the high-power view it is difficult to confidently identify the small to medium-sized atypical lymphocytes among the other
hematopoietic cells (c). The atypical lymphocytes are highlighted by immunohistostaining with CD3 (d) with irregular nuclear contours and TIA-1 (e).
The neoplastic cells are positive for EBV by in situ hybridization (EBER; f and g, low and high-power views, respectively)
(See figure on previous page.)
Fig. 1 Case 1. Flow cytometric analysis of the marrow aspirate shows that the gated atypical lymphocytes express surface CD2 and CD56 but not
CD3 or CD7 (a-c). In addition, they express cytoplasmic CD3 but not TdT, indicating an NK-cell phenotype. Marrow trephine shows a hypercellular
marrow with extensive infiltration by small to medium-sized atypical lymphocytes (d and e, HE stains; original magnifications × 200
and × 1000, respectively). The tumor cells express cytoplasmic CD3 (f), TIA-1 (g) and EBER (h). Analyses of genomic copy number alteration using the
HumanCytoSNP-12 Beadchip (Illumina). i and j, These two panels show evidence of gain of one copy at 4q21-q35 (i) and 9p24-p13 (j) respectively.
B allele frequency (BAF) plot in both panels demonstrates an altered pattern of BAF (0.0, 0.33, 0.67 and 1.0), which is highlighted in a blue background.
Log R ratio plot displays no apparent alteration and this is most likely due to the presence of mosaicism in the region of chromosomal gain
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secondary marrow involvement, or (iii) PMBL. i)
ANKL occurs mainly in young adults and shares the
same immunophenotype and EBV association with
ENKTL. Unlike our cases, patients with ANKL usually
have skin rashes, lymphadenopathy, and hepatospleno-
megaly and most importantly, leukemic cells in PB [7].
ii) ENKTL with marrow involvement usually occur
metachronously or concomitantly with involvement of
other anatomical sites such as the aerodigestive tract [8, 9].
In our patients, examination of the upper aerodiges-
tive tract with biopsy was negative. Neither patient
had cutaneous or gastrointestinal lesions. Although CT
scans revealed splenomegaly in both cases, there was no
nodular lesion/mass or lymphadenopathy. Positron emis-
sion tomography (PET)-CT is currently the standard for
detecting lymphoma but was not performed in our
patients [10]. However, both patients received Gallium
scan as part of infectious/inflammatory source workup.
Although less sensitive, gallium scans were negative in
both patients. iii) Accordingly, our cases fit the criteria of
PBML of NK-cell origin. Nasal ENKTL may show min-
imal involvement of the BM and PB at disease dissemin-
ation, but extensive marrow involvement is extremely
rare [11]. The other differential diagnosis is intravascular
lymphoma (IVL), frequently of B-cell phenotype with
rare examples of T- and/or NK-cell lineage; and the ex-
tremely rare cases with EBV association may share simi-
lar immunophenotype with ENKTL [12, 13]. Absence of
intravascular pattern in our cases argued against the
diagnosis of IVL.
There are only a few reports on genome-wide genetic
alterations of aggressive NK-cell neoplasms. Nakashima
et al. compared ANKL (n = 10) with ENKTL (n = 17)
using array CGH [3]. The recurrent alterations of
ANKLs were gain of 1q and loss of 7p15.1-p22.3 and
17p13.1, while that of ENKTL were gain of 2q, and loss
of 6q16.1-q27, 11q22.3-q23.3, 5p14.1-p14.3, 5q34-q35.3,
1p36.23-p36.33, 2p16.1-p16.3, 4q12, and 4q31.3-q32.1.
They considered ANKL and ENKTL distinct entities
based on different genetic alterations. Recently the same
group lumped ANKL (n = 9) and ENKTL (n = 27) to-
gether and identified two 6q21 regions that were most
frequently deleted (14 of 39 or 36 %) using oligo-array
CGH and gene-expression profiling [14]. They identified
several candidate tumor-suppressor genes that were
down-regulated in these regions and their subsequent
investigations suggested that two of these suppressor
genes, PRDM1 and FOXO3, were considered playing
an important role in the pathogenesis of NK-cell neo-
plasms. However, the genetic alterations in our Case
one (Chromosomes 4 and 9) were distinct from that
in these 2 reports. Studies on more cases are war-
ranted to elucidate the pathogenesis of this rare group
of disease.
Conclusions
In brief, we describe the clinicopathological findings of
two aggressive NK-cell neoplasms as PBML with poor
outcome, partly due to a delay in diagnosis. Patients with
this aggressive neoplasm may benefit from early and
accurate diagnosis and administration of novel thera-
peutic regimens such as SMILE (L-asparaginase,
methotrexate, ifosphamide, etoposide, and dexamethasone)
protocol, which could overcome the effects of increased
P-glycoprotein by the neoplastic NK-cells through the
expression of the multi-drug resistance (MDR) gene.
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